Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Cryoport announced Novartis has signed an agreement contracting Cryoport over an initial three-year term for cryogenic logistics support of CTL019/CD19 CAR-T cell therapy.
read more
Monday, February 05, 2018
Cryoport announced that the company will support TiGenix as it conducts its SEPCELL phase Ib/IIa clinical study.
read more
Cryoport announced it will provide its cold chain logistics solutions to support Nohla Therapeutics' clinical studies evaluating its universal donor cell therapy, NLA101.
read more
Wednesday, January 20, 2016
Cryoport, Inc. and Morphotek® have announced that Cryoport is providing end-to-end cold chain logistics support for shipments of Morphotek’s research and development materials.
read more
Cryoport announced the expansion of its global supply chain network by signing an agreement to acquire CRYOPDP, a provider of temperature-controlled logistics solutions.
read more
Cryoport, Inc. has signed a new three-year supply chain solutions agreement with Monash IVF Group Limited, a provider of assisted reproductive services, as well as specialist women’s imaging and diagnostic services in Australia and Southeast Asia.
read more
Cryoport announced financial results for the first quarter ended March 31, 2017.
read more
Thursday, February 10, 2022
Cryoport, Inc. has provided an update on resumption of activities at the New Prague facility. As previously announced, a fire occurred in a portion of the MVE Biological Solutions manufacturing facility located in New Prague, Minnesota on January 25,...
read more
Cryoport and Medipal Holdings announced a multi-year strategic business alliance agreement to create an integrated regenerative medicine supply chain solution in Japan.
read more
Cryoport, Inc. a temperature-controlled logistics company serving the life sciences industry, has initiated a novel and comprehensive logistics study to evaluate the impact of temperature and transport packaging at deep frozen temperatures on ...
read more
Tuesday, February 28, 2017
The Cryoport Biotech Regenerative Therapy Activity Index (the "CoBRA IndexSM") quantifies the activity in the development and clinical trials of regenerative therapies in the United States, and acts as a means by which investors, the media and ...
read more
The Cryoport. Certified. Cool. solution is designed to provide cold-chain logistics in the 2 – 8 degrees Celsius temperature range for regenerative therapy requirements.
read more
Friday, September 20, 2019
Cryoport announced the launch of its Advanced Therapy Shipper™ product line for the regenerative medicine market.
read more
Tuesday, December 01, 2015
Cryoport, a cryogenic logistics company has been selected by QPS Hepatic Biosciences, a subsidiary of QPS Holdings LLC, as its cryogenic logistics partner supporting QPS's cryopreserved hepatocytes businesses in the USA and the EU, further augmenting...
read more
Cryoport, Inc. has announced that its wholly owned operating companies, Cryoport Systems and CRYOPDP, have jointly opened a new Global Logistics Center in Singapore.
read more